Colchicine a New Tool for Stroke, CVD Event Recurrence?
The CONVINCE trial of the anti-inflammatory drug colchicine missed its primary endpoint, but secondary analyses suggested benefit.
Source: medscape.com
Novel Target News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Novel Target. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Novel Target Today - Breaking & Trending Today
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
– Sixteen oral presentations, as well as a plenary session and poster presentations, highlight new advances across eight of the Company’s medicines – Plenary Scientific Session will feature...
Source: marketscreener.com
Sarcoma Foundation of America Announces 2022 Research Grant Awards
The Sarcoma Foundation of America (SFA), an organization dedicated to increasing research and awareness for sarcoma, today announced that it has awarded close
Source: einnews.com
World AI for Drug Target Discovery and Validation Market
Dublin, July 20, 2022 (GLOBE NEWSWIRE) -- The "Growth Opportunities in AI for Drug Target Discovery and Validation" report has been added to...
Source: globenewswire.com